Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
9.32
-0.08 (-0.85%)
Oct 16, 2026, 3:04 PM CST
SHE:002399 Market Cap
SHE:002399 has a market cap or net worth of 12.37 billion as of October 16, 2026. It is the 6,982nd most valuable company in the world and the 1,293rd biggest in China. Its market cap has decreased by 21.82% in one year.
Market Cap
12.37B
Enterprise Value
11.87B
Revenue
5.24B
Global Rank
Country Rank
#1,293 China
PE Ratio
67.39
ChartMarket Cap Chart
Since May 6, 2010, SHE:002399's market cap has decreased from 70.09B to 12.37B, a decrease of -82.35%. That is a compound annual growth rate of -10.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 12.37B | -21.40% |
| Dec 31, 2025 | 15.73B | 11.19% |
| Dec 31, 2024 | 14.15B | -7.78% |
| Dec 29, 2023 | 15.34B | -10.21% |
| Dec 30, 2022 | 17.09B | -25.00% |
| Dec 31, 2021 | 22.79B | -3.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 13.75B |
| Fujian Cosunter Pharmaceutical | 13.44B |
| Nanjing King-Friend Biochemical Pharmaceutical | 13.16B |
| Zhejiang Hisun Pharmaceutical | 12.70B |
| Guobang Pharma | 12.23B |
| Henan Lingrui Pharmaceutical | 11.94B |
| Beijing Aosaikang Pharmaceutical | 11.81B |
| Zhejiang Medicine | 11.49B |